With every purchase, Capelle will donate a part of its profits to the Miami Cancer Institute.
Skin cancer is the most common cancer in the United States. Current estimates are that one in five Americans will develop skin cancer in their lifetime. It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day.
These facts are the driving force behind Capelle’s mission. Capelle is dedicated to help solve this problem and to bring awareness to a rising threat in the United States.
Our company is built from the ground up around the idea of sharing gratitude. At Capelle Miami we made our mission to donates as we grow. Our giving and community efforts will continue to grow right alongside us. For every item sold, Capelle will donate a part of our profits to the Miami Cancer Institute.
At Capelle Miami we are committed to more than just giving. We want to share a socially conscious model to inspire people and other businesses to give back.
LEARN MORE ABOUT SKIN CANCER:
1Guy GP, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: Melanoma incidence and mortality trends and projections—United States, 1982–2030. MMWR Morb Mortal Wkly Rep. 2015;64(21):591-596.
2Guy GP, Machlin S, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the US, 2002–2006 and 2007–2011. Am J Prev Med. 2015;48:183–7.
3Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol. 2010 Mar;146(3):279-82.
4Robinson JK. Sun Exposure, Sun Protection, and Vitamin D. JAMA 2005; 294: 1541-43.
5Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population. JAMA Dermatol. Published online April 30, 2015.
6American Cancer Society. Cancer Facts & Figures 2018. Atlanta: American Cancer Society; 2018.